MedTrace Logo

Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing

NCT01447680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2015-09-07

No results posted yet for this study

Summary

The purpose of this study is to compare the results for HIV and/or Hepatitis C Virus antibody testing when using routine plasma versus SMARTplasma from the same blood sample. SMARTplasma is enriched for antibodies via a stimulation step of whole blood in a SMARTube™ (SMARTstim™ in the USA).

Conditions

  • Human Immunodeficiency Virus Infection
  • Hepatitis C

Sponsors & Collaborators

  • Alquest

    collaborator INDUSTRY

  • SMART Biotech Ltd

    collaborator UNKNOWN

  • G & W Laboratories Inc.

    lead INDUSTRY

Principal Investigators

  • Niel Constantine, Ph.D. · University of Maryland, Baltimore

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01447680 on ClinicalTrials.gov